Abstract：
OBJECTIVE: To examine the available literature to better understand the objective and patient-reported outcomes using peroneus longus tendon (PLT) autograft compared with more commonly used autografts, such as the quadrupled hamstring tendons (HT), in patients undergoing primary for anterior cruciate ligament reconstruction (ACLR).
METHODS: A comprehensive search of published literature in PubMed, Web of Science, Cochrane Library, Ovid, and EMBASE databases was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria included patients undergoing ACLR with PLT autograft, inclusion of patient-recorded outcome measures, and availability in English language. Publications that included only biomechanical analysis or ACLR with use of allograft or combination grafts were excluded.
RESULTS: A total of 16 studies (Level of Evidence range: I-IV) met inclusion criteria, with follow-up ranging from 3 months to 5 years. In the available case series, patient-reported outcomes ranged from Lysholm = 80.7 to 95.1, International Knee Documentation Committee 78.1 to 95.7. In prospective cohorts and randomized controlled trials, PLT performance was comparable with HT autografts (PLT/HT: Lysholm = 88.3-95.1/86.5-94.9, International Knee Documentation Committee = 78.2-92.5/87.4-93.4). The majority of PLT grafts diameters were equal or greater than HT counterparts with a mean of >8 mm (PLT/HT: 7.0-9.0 mm/7.65-8.5 mm). There was minimal donor-site morbidity associated with PLT harvest.
CONCLUSIONS: Although limitations exist within the available literature, existing evidence suggests that PLT autograft routinely produces adequately sized grafts with comparable early outcomes to HT autograft and low risk of donor-site morbidity. However, the PLT autograft is yet to demonstrate superiority to any of the more-traditional autograft selections.
METHODS: Level IV, systematic review of Level I-IV studies.
METHODS: A comprehensive search of published literature in PubMed, Web of Science, Cochrane Library, Ovid, and EMBASE databases was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Inclusion criteria included patients undergoing ACLR with PLT autograft, inclusion of patient-recorded outcome measures, and availability in English language. Publications that included only biomechanical analysis or ACLR with use of allograft or combination grafts were excluded.
RESULTS: A total of 16 studies (Level of Evidence range: I-IV) met inclusion criteria, with follow-up ranging from 3 months to 5 years. In the available case series, patient-reported outcomes ranged from Lysholm = 80.7 to 95.1, International Knee Documentation Committee 78.1 to 95.7. In prospective cohorts and randomized controlled trials, PLT performance was comparable with HT autografts (PLT/HT: Lysholm = 88.3-95.1/86.5-94.9, International Knee Documentation Committee = 78.2-92.5/87.4-93.4). The majority of PLT grafts diameters were equal or greater than HT counterparts with a mean of >8 mm (PLT/HT: 7.0-9.0 mm/7.65-8.5 mm). There was minimal donor-site morbidity associated with PLT harvest.
CONCLUSIONS: Although limitations exist within the available literature, existing evidence suggests that PLT autograft routinely produces adequately sized grafts with comparable early outcomes to HT autograft and low risk of donor-site morbidity. However, the PLT autograft is yet to demonstrate superiority to any of the more-traditional autograft selections.
METHODS: Level IV, systematic review of Level I-IV studies.
摘要：
目的：本文的目的是研究现有文献，以更好地了解使用PLT自体移植物与更常用的自体移植物相比的客观和患者报告的结果。例如四腿筋肌腱(HT)，在接受原发性ACLR的患者中。
方法：对Pub-Med，WebofScience,科克伦图书馆,Ovid和EMBASE数据库是根据系统审查和Met分析（PRISMA）指南的首选报告项目进行的。纳入标准包括接受ACLR与PLT自体移植的患者，纳入患者记录的结果测量，以及英语语言的可用性。仅包括生物力学分析的出版物，排除使用同种异体移植物或组合移植物的ACLR。
结果：共有16项研究（证据水平范围：I-IV）符合纳入标准，随访时间为3个月至5年。在可用的案例系列中，患者报告的结局范围为Lyshom=80.7-95.1,IKDC78.1-95.7.在前瞻性队列和随机对照试验中，PLT性能与绳肌腱（HT）自体移植物相当（PLT/HT：Lysholm=88.3-95.1/86.5-94.9，IKDC=78.2-92.5/87.4-93.4）。大多数PLT移植物直径等于或大于HT对应物，平均>8mm（PLT/HT：7.0-9.0mm/7.65-8.5mm）。与PLT收获相关的供体部位发病率最低。
结论：尽管现有文献中存在限制，现有证据表明,PLT自体移植物常规产生足够大小的移植物,其早期结局与HT自体移植物相当,且供体部位发病率低.然而,PLT自体移植物尚未显示出优于任何更传统的自体移植物选择。
方法：对Pub-Med，WebofScience,科克伦图书馆,Ovid和EMBASE数据库是根据系统审查和Met分析（PRISMA）指南的首选报告项目进行的。纳入标准包括接受ACLR与PLT自体移植的患者，纳入患者记录的结果测量，以及英语语言的可用性。仅包括生物力学分析的出版物，排除使用同种异体移植物或组合移植物的ACLR。
结果：共有16项研究（证据水平范围：I-IV）符合纳入标准，随访时间为3个月至5年。在可用的案例系列中，患者报告的结局范围为Lyshom=80.7-95.1,IKDC78.1-95.7.在前瞻性队列和随机对照试验中，PLT性能与绳肌腱（HT）自体移植物相当（PLT/HT：Lysholm=88.3-95.1/86.5-94.9，IKDC=78.2-92.5/87.4-93.4）。大多数PLT移植物直径等于或大于HT对应物，平均>8mm（PLT/HT：7.0-9.0mm/7.65-8.5mm）。与PLT收获相关的供体部位发病率最低。
结论：尽管现有文献中存在限制，现有证据表明,PLT自体移植物常规产生足够大小的移植物,其早期结局与HT自体移植物相当,且供体部位发病率低.然而,PLT自体移植物尚未显示出优于任何更传统的自体移植物选择。
